ARTICLE | Clinical News
Obio preclinical data
March 16, 2009 7:00 AM UTC
Obio's TG21 decreased the amount of virus and increased the survival rate of chick embryos, chicks and mice challenged with the H5N1 strain of influenza. The undisclosed active ingredient in TG21 is a...